已发表论文

微小 RNA-425 通过靶向一类解聚素(A disintegrin)和金属蛋白酶 9 促进肺腺癌的发展(ADAM9)

 

Authors Liu R, Wang F, Guo Y, Yang J, Chen S, Gao X, Wang X

Received 26 December 2017

Accepted for publication 4 May 2018

Published 16 July 2018 Volume 2018:11 Pages 4065—4073

DOI https://doi.org/10.2147/OTT.S160871

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Andrew Yee

Peer reviewer comments 3

Editor who approved publication: Dr Jianmin Xu

Purpose: We aimed to investigate the roles of microRNA-425 (miR-425) in lung adenocarcinoma, as well as its possible regulatory mechanism.
Materials and methods: The miR-425 expression in lung adenocarcinoma tissues and cells was determined. The regulatory relationship between miR-425 and IL-6/STAT3 signaling was investigated. In addition, miR-425 was downexpressed in H1299 cells, and its effects on cell proliferation and apoptosis were determined. Furthermore, the target relationship between miR-425 and A disintegrin and metalloproteinases 9 (ADAM9) in lung adenocarcinoma cells was explored.
Results: The miR-425 was significantly downregulated in lung adenocarcinoma tissues and cells and was markedly inhibited by IL-6/STAT3 signaling. In addition, miR-425 expression was successfully overexpressed by transfection with pre-miR-425. Overexpression of miR-425 decreased the proliferation and colony formation of H1299 cells and promoted cell apoptosis markedly. Moreover, ADAM9 was revealed as a target of miR-425, and ADAM9 expression was negatively regulated by miR-425.
Conclusion: Our findings indicate that downregulation of miR-425 caused by IL-6/STAT3 signaling leads to loss of ADAM9 targeting, results in enhanced ADAM9 expression, and contributes to the development of lung adenocarcinoma. Thus, increasing miR-425 may be a promising therapeutic strategy for this disease.
Keywords: lung adenocarcinoma, microRNA-425, IL-6/STAT3 signaling, proliferation, apoptosis, A disintegrin and metalloproteinases 9




Figure 1 miR-425 was significantly downregulated in lung adenocarcinoma tissues and cells.